PINOROX
LIVE

Serial Number

97886931

Owner

AMBE PHYTOEXTRACTS PRIVATE LIMITED

Attorney

Geza C. Ziegler, Jr.

First Use Date

Oct 16, 2023

Filing Date

Apr 13, 2023

Add to watchlist:

No watchlists yet
View on USPTO

PINOROX Trademark

Serial Number: 97886931 • Registration: 7655461

PINOROX is a trademark filed by AMBE PHYTOEXTRACTS PRIVATE LIMITED on April 13, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

AMBE PHYTOEXTRACTS PRIVATE LIMITED (2 trademarks)

D-202, Plot No.-55
East Delhi, Delhi 110092 , IN

Entity Type: 99

Trademark Details

Filing Date

April 13, 2023

Registration Date

January 14, 2025

First Use Anywhere

October 16, 2023

First Use in Commerce

October 16, 2023

Published for Opposition

February 20, 2024

Goods & Services

Medicinal plant extracts sold as an integral component of powdered nutritional supplement drink mixes; Medicinal plant extracts sold as an integral component of anti-inflammatories; Medicinal plant extracts sold as an integral component of nutritional supplements; Medicinal plant extracts sold as an integral component of dietary supplements for promoting blood circulation; Medicinal plant extracts sold as an integral component of nutritional and dietary supplements; Medicinal plant extracts sold as an integral component of nutritional and dietary supplements for relieving muscle soreness; Medicinal plant extracts sold as an integral component of nutritional and dietary supplements for preventing oxidative stress; Medicinal plant extracts sold as an integral component of nutritional and dietary supplements for promoting heart, skin, eyes, bones and joint health; Medicinal plant extracts sold as an integral component of dietary supplements for the management of clinical symptoms associated with diabetes; Medicinal plant extracts sold as an integral component of dietary supplements for the management of menstrual symptoms; Medicinal plant extracts sold as an integral component of pharmaceuticals for the management of clinical symptoms associated with erectile dysfunction

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 14, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 14, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 23, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 23, 2024 CNPR
EXAMINER'S AMENDMENT ENTERED
Dec 18, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 18, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 18, 2024 GNEA
SU-EXAMINER'S AMENDMENT WRITTEN
Dec 18, 2024 SNEA
STATEMENT OF USE PROCESSING COMPLETE
Dec 10, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 9, 2024 AITU
USE AMENDMENT FILED
Oct 1, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 1, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 16, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 4, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 20, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 31, 2024 NONP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 31, 2024 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 12, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 12, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 12, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 12, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 12, 2024 CNEA
ASSIGNED TO EXAMINER
Jan 9, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 8, 2023 NWOS
NEW APPLICATION ENTERED
Apr 17, 2023 NWAP